GoodRx HoldingsGDRX +3.70%60 PB Ratio is 1.52 as of Jun. 28, 2026, which is 49% below its 10-year median of 3.00. GuruFocus rates GDRX with a GF Score™ of 60/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 608 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 61.35% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-28), GoodRx Holdings's share price is $2.80. GoodRx Holdings's Book Value per Share for the quarter that ended in Mar. 2026 was $1.84. Hence, GoodRx Holdings's PB Ratio of today is 1.52.
The historical rank and industry rank for GoodRx Holdings's PB Ratio or its related term are showing as below:
GDRX'
s PB Ratio Range Over the Past 10 Years
Min: 1.03 Med: 3 Max: 31.18
Current: 1.52
During the past 8 years, GoodRx Holdings's highest PB Ratio was 31.18. The lowest was 1.03. And the median was 3.00.
GDRX's PB Ratio is ranked better than 61.35% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.985
vs GDRX: 1.52
During the past 12 months, GoodRx Holdings's average Book Value Per Share Growth Rate was 1.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -4.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -1.00% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of GoodRx Holdings was 2.10% per year. The lowest was -4.10% per year. And the median was -3.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
GoodRx Holdings PB Ratio Related Terms
GoodRx Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for GoodRx Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GoodRx Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
GoodRx Holdings's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
GoodRx Holdings (GDRX) has a PB Ratio of 1.52 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on GoodRx Holdings and its competitors. This is 49% below median its historical median of 3.00. Over the past decade, GoodRx Holdings' PB Ratio has ranged from 1.03 to 31.18. According to the industry distribution chart, GoodRx Holdings ranks #235 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 38.7%.
Is GoodRx Holdings' PB Ratio too high?
GoodRx Holdings' current PB Ratio of 1.52 is 49% below median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 31.18. The Healthcare Providers & Services industry median PB Ratio is 1.99. GoodRx Holdings' value of 1.52 is 23.4% below this industry median. Based on the distribution chart, GoodRx Holdings ranks #235 out of 608 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GoodRx Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' PB Ratio compare to OMDA and CERT?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #235 out of 608 companies for PB Ratio. This puts GoodRx Holdings in the upper half of its industry. The industry median PB Ratio is 1.99. GoodRx Holdings' value of 1.52 is 23.4% below this benchmark. Historically, GoodRx Holdings' own PB Ratio has ranged from 1.03 to 31.18 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 1.99, GoodRx Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current PB Ratio of 1.52 is 23.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on GoodRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current PB Ratio is 1.52, which is 49% below median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $2.80 — trading 50.5% below its estimated fair value. The current PB Ratio is 1.52, which is 49% below median its 10-year median of 3.00 and 23.4% below the Healthcare Providers & Services industry median of 1.99. GoodRx Holdings' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current PB Ratio is 1.52 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $2.80 is trading 50.5% below its estimated GF Value™ of $5.66.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
PB Ratio: 1.52 (49% below median its 10-year median of 3.00)
GF Value™: $5.66 vs. price of $2.80 (50.5% below fair value)
Industry Position: 23.4% below the Healthcare Providers & Services median (#235 of 608)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
60GF Score
Get the complete analysis for GDRX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
